Impact of the COVID-19 pandemic on treatment in patients (pts) with gynecological (GYN) cancer: A comparison with 2019 data from Guy’s Cancer Centre.
Vasiliki Michalarea(Royal Marsden Hospital), Rebecca Kristeleit(Guy's and St Thomas' NHS Foundation Trust), Mieke Van Hemelrijck(Ghent University Hospital), Rahul Nath(Guy's and St Thomas' NHS Foundation Trust), Anne Rigg(National Health Service), Benjamin A. Taylor(Dalhousie University), Kalliopi Michoglou(Euromedica), K. Eremeishvili(Guy's and St Thomas' NHS Foundation Trust), Saoirse Dolly(Guy's and St Thomas' NHS Foundation Trust), Ingrid White(Guy's and St Thomas' NHS Foundation Trust), Charlotte Moss(Southampton General Hospital), Rushan Sylva(Guy's and St Thomas' NHS Foundation Trust), Beth Russell(King's College London), Styliani Germanou(Guy's and St Thomas' NHS Foundation Trust), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Sharmistha Ghosh(Guy's and St Thomas' NHS Foundation Trust), Liam Cain(Guy's and St Thomas' NHS Foundation Trust), Andreja Podvez Nevajda(Guy's and St Thomas' NHS Foundation Trust), Gautam Mehra(Guy's and St Thomas' NHS Foundation Trust), Ahmad Sayasneh(Imperial College Healthcare NHS Trust)
Cited by 0
Related Papers
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|614
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
|The Lancet Oncology|2021|401
Prevalence and demography of transsexualism in Belgium
|European Psychiatry|2007|306